台股 » 個股 » 東生華 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

東生華

(8432)
可現股當沖
  • 股價
    59.3
  • 漲跌
    ▼0.5
  • 漲幅
    -0.84%
  • 成交量
    24
  • 產業
    上櫃 生技醫療類股
  • 36人加入追蹤

    立即追蹤

  • 本地時間:13:30(已收盤)

     
東生華 (8432)籌碼相關-台新-台中 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

台新-台中 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2025/01/1500.00258.0057.60-286-2.32%
2025/01/07262.2000.0062.2021011.97%
2024/12/0400.00165.3065.10-1143-0.70%
2024/11/20163.8000.0063.8011480.67%
2024/11/1100.00167.4065.50-1136-0.73%
2024/11/06162.9000.0062.8011430.70%
2024/11/0400.00565.2064.70-5145-3.43%
2024/10/28165.6000.0065.5011520.66%
2024/10/2300.00565.5065.40-5168-2.96%
2024/10/2100.00165.3064.90-1166-0.60%
2024/10/1400.00465.5365.70-4160-2.50%
2024/10/1100.00262.2062.50-2155-1.29%
2024/10/09264.201063.7262.20-8153-5.20%
2024/10/08463.501763.9863.20-13150-8.66%
2024/10/0100.00258.7058.60-2135-1.47%
2024/09/251858.9600.0058.801814012.81%
2024/09/181256.8100.0056.30121577.64%
2024/09/1100.00155.2054.80-1162-0.61%
2024/09/0900.00556.9056.80-5162-3.08%
2024/09/06157.7000.0057.0011630.61%
2024/09/040.157.0000.0057.400.11670.06%
2024/08/3000.00060.2059.8001740.00%
2024/08/27560.5800.0059.7051772.82%
2024/08/16257.9000.0057.8021871.07%
2024/08/14156.3000.0056.2011930.52%
2024/08/13256.3500.0056.5021981.01%
2024/08/09156.3000.0056.2012030.49%
2024/08/08456.4300.0056.2042011.99%
2024/08/0100.000.364.9065.50-0.3230-0.13%
2024/07/310.164.9000.0064.600.12320.04%
2024/07/2600.00160.9060.60-1218-0.46%
2024/07/15162.4000.0062.5012360.42%
2024/07/090.162.4000.0061.500.12320.04%
2024/07/080.165.30163.4063.50-0.9229-0.39%
2024/06/27169.5000.0068.8012310.43%
2024/06/2600.00169.0069.80-1230-0.43%
2024/06/25170.0000.0068.3012270.44%
2024/06/1200.00364.1764.20-3220-1.36%
2024/06/1100.00168.0066.70-1217-0.46%
2024/06/0700.00266.5566.30-2217-0.92%
2024/06/06666.97366.8067.1032171.38%
2024/06/03165.3000.0064.9012220.45%
2024/05/280.162.2000.0061.900.12440.04%
2024/05/2200.000.267.0066.10-0.2275-0.06%
2024/05/21366.9300.0066.3032891.03%
2024/05/1700.00367.5066.10-3306-0.98%
2024/05/13165.90264.8064.30-1322-0.31%
2024/05/10267.80166.1066.0013190.31%
2024/05/09368.03168.0067.1023130.64%
2024/05/08164.30165.3064.4002990.00%
2024/04/3000.00158.6058.60-1265-0.38%
2024/04/2400.00258.8059.50-2257-0.78%
2024/04/23260.60161.5060.7012550.39%
2024/04/22156.70156.5056.7002480.00%
2024/04/19155.0000.0054.7012470.40%
2024/04/16155.00155.7055.0002570.00%
2024/04/0100.00158.6058.20-1250-0.40%
2024/03/2500.00157.3057.60-1249-0.40%
2024/03/19155.3000.0055.4012500.40%
2024/03/07156.9000.0056.6012450.41%
2024/03/0500.00160.8061.20-1228-0.44%
2024/03/04163.80264.8061.10-1226-0.44%
2024/02/29162.50463.1063.60-3220-1.36%
2024/02/27363.67263.2064.3012160.46%
2024/02/23263.0500.0061.0022020.99%
2024/02/22361.10461.0360.00-1193-0.52%
2024/02/200.256.4000.0056.300.21630.11%
2024/02/1900.00156.9056.00-1161-0.62%
2024/02/16856.76856.6957.2001610.00%
東生華加速16項新品專案開發 目標未來5年營收翻倍Anue鉅亨-2024/12/20
東生華液態切片技術新突破 成功識別92%肺癌基因突變Anue鉅亨-2024/08/26
東生華攜手陽明交大簽署MOU 聚焦人才培育、精準藥物開發Anue鉅亨-2024/07/22
東生華 相關文章